Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00361257 · ClinicalTrials.gov registry record · Phase 2
Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
A Phase 2 study, sponsored by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.
- Terminated
- Registry status
- Phase 2
- Development phase
- 107
- Enrollment target
NCT00361257 is a Phase 2 study that was terminated before completion, run by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections. The registered enrollment target is 107 participants.
The verdict
NCT00361257, a Phase 2 study, was terminated before completion, sponsored by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 107 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effectiveness of minocycline, an antibiotic, in lessening the decreased mental function sometimes caused by anti-HIV drugs.
Interventions
- DRUG Minocycline
- DRUG Placebo (Tetracycline)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2007-03 |
| Est. Completion | 2010-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00361257
The ClinicalTrials.gov registry entry for NCT00361257 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Minocycline is the first listed.
NCT00361257 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00361257 about?
NCT00361257 is a clinical study titled "Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults". The purpose of this study is to determine the effectiveness of minocycline, an antibiotic, in lessening the decreased mental function sometimes caused by anti-HIV drugs.
What is the current status of trial NCT00361257?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 107 participants. The study started on 2007-03. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00361257?
The interventions under investigation include: Minocycline (DRUG), Placebo (Tetracycline) (DRUG).
Who is sponsoring clinical trial NCT00361257?
This trial is sponsored by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.